Furthermore, knocking down 2,4-dienoyl–CoA reductase (DECR1), an enzyme involved in fatty acid oxidation, causes cellular accumulation of PUFAs and enhances mitochondrial oxidative stress and lipid peroxidation in human prostate cancer (53). Here, DECR1 is linked to prostate carcinoma.